Dental Pain Study of Analgesics in Patients Undergoing Molar Removal
Completed · Phase 2 · Has a placebo group
Conditions studied: Dental Pain
In brief
* Accessing the efficacy and safety of pregabalin when used alone and in combo with acetaminophen in a dental pain model. * To test whether pre-operative dose of pregabalin increases the time to significant post-operative pain (NRS ≥ 5), and hence time to first analgesia consumed post-operatively.
Key facts
- Study ID
- NCT03652818
- Run by
- Nevakar, Inc.
- People needed
- 115
- Starts
- 2018-06-15
- Expected to finish
- 2018-09-20
- Last updated by the study team
- 2021-11-23
Who can join
Age: 17 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients who are scheduled to undergo the surgical removal of up to 4 third molars of which at least 2 have to be mandibular molars with a difficulty rating of 4 or 5.
- Patient must have a negative urine drug screen for drugs of abuse (including tobacco) at screening and at the day of surgery.
- No alcohol for a minimum of 1 day prior to the surgery.
You may not qualify if…
- Patients should not be experiencing oral infections or symptoms of concomitant illness at the time of a scheduled surgery.
- Patients with a history of any type of malignancy within the past 5 years other than minor skin related cancers.
- Patients who currently have or have had a history of uncontrolled hypertension.
- Patients with a known allergy or hypersensitivity to any local anesthetic drug, NSAIDs, gabapentin or pregabalin;.
- Patients with conditions that affect the absorption, metabolism, or passage of drugs out of the body (e.g., sprue, celiac disease, crohn's disease, etc.)
Where it is running
- Jean Brown Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.